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Cloning and Characterization of Chicken IL-10 and Its Role in
the Immune Response to Eimeria maxima1
Lisa Rothwell,* John R. Young,* Rima Zoorob,† Catherine A. Whittaker,* Pat Hesketh,*
Andrew Archer,* Adrian L. Smith,* and Pete Kaiser2*
We isolated the full-length chicken IL-10 (chIL-10) cDNA from an expressed sequence tag library derived from RNA from cecal
tonsils of Eimeria tenella-infected chickens. It encodes a 178-aa polypeptide, with a predicted 162-aa mature peptide. Chicken
IL-10 has 45 and 42% aa identity with human and murine IL-10, respectively. The structures of the chIL-10 gene and its promoter
were determined by direct sequencing of a bacterial artificial chromosome containing chIL-10. The chIL-10 gene structure is
similar to (five exons, four introns), but more compact than, that of its mammalian orthologues. The promoter is more similar to
that of Fugu IL-10 than human IL-10. Chicken IL-10 mRNA expression was identified mainly in the bursa of Fabricius and cecal
tonsils, with low levels of expression also seen in thymus, liver, and lung. Expression was also detected in PHA-activated thymo-
cytes and LPS-stimulated monocyte-derived macrophages, with high expression in an LPS-stimulated macrophage cell line.
Recombinant chIL-10 was produced and bioactivity demonstrated through IL-10-induced inhibition of IFN- synthesis by mi-
togen-activated lymphocytes. We measured the expression of mRNA for chIL-10 and other signature cytokines in gut and spleen
of resistant (line C.B12) and susceptible (line 15I) chickens during the course of an E. maxima infection. Susceptible chickens
showed higher levels of chIL-10 mRNA expression in the spleen, both constitutively and after infection, and in the small intestine
after infection than did resistant chickens. These data indicate a potential role for chIL-10 in changing the Th bias during infection
with an intracellular protozoan, thereby contributing to susceptibility of line 15I chickens. The Journal of Immunology, 2004, 173:
2675–2682.
I n mammals, IL-10 is a 17- to 19-kDa cytokine containingtwo disulfide bridges that functions as a homodimer. It isproduced by activated T cells, B cells, monocytes/macro-
phages, mast cells, and keratinocytes (1). The genes for human and
murine IL-10, both consisting of five exons and four introns, lie on
syntenic regions of chromosome 1 in both species. IL-10 is a 4-
helical bundle cytokine (2) and exerts its biological effects through
binding to a type II cytokine receptor (3).
Recently, it has emerged that IL-10 is the signature member of
a family of cytokines, including both cellular (IL-19 (4), IL-20 (5),
IL-22 (6, 7), IL-24 (8), and IL-26 (9)) and virally encoded (BCRF1
of EBV (10, 11) and other IL-10 homologues in equine herpes
virus type 2 (12), the Orf (13) and Yaba-like disease (14) poxvi-
ruses, and CMV (15, 16)) cytokines, which share limited primary
sequence identity and probable structural homology. For most of
these IL-10-like cytokines, function has yet to be fully determined.
The predominant effect of IL-10 in mammals is to modify im-
mune responses through direct effects on many cell types, includ-
ing T cells, B cells, APCs, and NK cells, promoting the develop-
ment of T2 responses (17, 18). In particular, it inhibits the
synthesis of proinflammatory cytokines (including IL-1, TNF-,
and IL-12) both at the level of transcription and post-transcription-
ally, NO production, and MHC class II expression (19–21), thus
down-regulating inflammatory (T1) responses. It therefore also
promotes T2 responses by inhibiting T1 cytokines (22, 23).
Most of what we know about the role of IL-10 in infectious
disease comes from murine models. Manipulating levels of IL-10
in vivo, either with rIL-10 or anti-IL-10 Abs or by using IL-10
knockout mice, alters the T1/T2 bias of the immune response and
hence affects protection against infectious agents and/or pathology.
In general, low levels of IL-10 increase resistance, and high levels
increase susceptibility, to intracellular pathogens, including bacte-
ria, viruses, and protozoa (reviewed in Ref. 24).
The intracellular protozoan Eimeria spp. causes a serious enteric
disease in a wide range of animal species. Coccidiosis, caused by
Eimeria spp., is an economically important disease for the poultry
industry and is still mainly controlled by medication, but because
of ever-present drug resistance and the withdrawal of many drugs,
vaccination is increasingly practiced (25). For further progress in
vaccination against coccidiosis, a clear understanding of the mech-
anisms involved in the very effective protective responses nor-
mally induced by infection will be required. These mechanisms are
now well understood in the mouse model, but to a lesser degree in
the chicken. In the former, the response is IFN-- and T1-domi-
nated, and with at least some Eimeria spp., IFN- is produced by
CD4 T cells (26, 27).
Inbred lines of chickens differ in their resistance or susceptibility
to infection with Eimeria maxima and Eimeria tenella (28, 29). In
chickens, the level of resistance correlates with the magnitude of
the T cell response, with higher proliferative responses in resistant
lines of chickens (30). In terms of the role of cytokines, the pro-
duction of proinflammatory and T1 cytokines, chemokines, and the
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anti-inflammatory cytokine TGF- has been described after infec-
tion of chickens with several species of Eimeria (27, 31–40). Dif-
ferences between inbred lines have been shown for IL-2 and
IFN-; levels of production of both were higher after either
primary infection or secondary challenge in resistant than in sus-
ceptible lines (32, 38).
Despite the general lack of cross-reactivity and the low level of
sequence identity (both DNA and amino acid) between avian cy-
tokines and their mammalian orthologues, there has been consid-
erable progress recently in cloning avian cytokines (41–43). How-
ever, several important cytokines, such as CSFs, TNFs, and the
IL-10 family, remain to be cloned in the chicken.
Our initial attempts to clone chicken IL-10 (chIL-10)3 used a
genomics approach based on conservation of synteny. As we pre-
pared to shotgun-sequence a candidate bacterial artificial chromo-
some (BAC) to identify chIL-10, we identified an expressed se-
quence tag (EST), from a cDNA library derived from RNA from
a cecal tonsil of a chicken infected with E. tenella, with identity
with mammalian IL-10. Because IL-10 can act as a negative reg-
ulator of T1 immune responses in mammals, which are important
in the control of many intracellular parasites (including the Eime-
ria spp.), we investigated the levels of IL-10 mRNA in various
tissues during infection of resistant and susceptible chickens with
E. maxima.
Materials and Methods
Experimental animals and parasites
Chickens of various inbred White Leghorn lines were produced and main-
tained at Institute for Animal Health (Compton, U.K.). Inbred lines 72 and
15I originate from the Regional Poultry Research Laboratory (East Lan-
sing, MI). Reaseheath C (C line) birds originate from University of Cam-
bridge (Cambridge, U.K.). All three lines have been maintained at Institute
for Animal Health for 20 years.
The Houghton strain of E. maxima was used (44). The strain is the
progeny of a single oocyst. Methods for maintaining the parasites, prepar-
ing infective doses, and quantifying infections by detecting or counting the
numbers of oocysts in feces between 5 and 10 days postinfection have been
described previously (45). E. maxima was passaged at frequent intervals
and was used within 21 days of sporulation for each experiment. All pas-
sage of the parasites in chickens was undertaken in separate isolated rooms,
each fitted with two antelobbies and fumigated before and after use with
methyl bromide. Furthermore, oocysts were recovered from fecal material
in purpose-built rooms, which were disinfected afterward by a minimum of
7 h of exposure to gaseous ammonia. All experiments were conducted in
methyl bromide-treated rooms to avoid the ingress of coccidial parasites.
BAC library screening
Partial cDNAs for chicken ligatin (clone 16m15r1, provided by J.-M. Buer-
stedde, University of Munich, Munich, Germany) and chicken poly-Ig re-
ceptor (this laboratory; data not shown) were labeled with [-32P]dCTP
using a random-primed labeling kit (Roche, Lewes, U.K.) and were used to
screen the Wageningen chicken BAC library (46). Eight BACs were pos-
itive for ligatin, and six were positive for poly-Ig receptor, with four BACs
(bW102M1, bW111G11, bW119H6, and bW134F8) containing both
genes. After identification of the chIL-10 EST and subsequent cloning of
the cDNA, the four BACs identified from the library screening were con-
firmed as containing chIL-10 by PCR. The positive BACs were subse-
quently sequenced, initially using primers specific to the cDNA, to gener-
ate the full-length chIL-10 gene, including the promoter. The chIL-10
cDNA and gene have been deposited in the databases with accession num-
bers AJ621254 and AJ621614, respectively.
Phylogenetic analysis
Chicken and selected mammalian IL-10 predicted amino acid sequences
were aligned using the CLUSTAL-X program. The alignment generated
was manipulated to obtain maximum sequence similarity. The programs
in the Phylogeny Inference Package (PHYLIP, version 3.572c, released
by J. Felsenstein, University of Washington, Seattle, WA, 1993) were
used to analyze the alignment. Distance (d) was calculated for all pairs
of sequences according to the formula d  loge (1  p  0.2p2) with
p being the proportion of observed aa differences. The tree was con-
structed by the Fitch-Margoliash method (47) and was drawn unrooted
using TreeView (48).
Production of recombinant chIL-10 (rchIL-10) by COS-7 cells
COS-7 cells were routinely grown in DMEM (Life Technologies, Paisley,
U.K.) containing 10% FBS (PAA Laboratories, Linz, Austria), 1% non-
essential amino acids, 1% L-glutamine, 1 U/ml penicillin, and 1 g/ml
streptomycin at 37°C in 5% CO2 and passaged using standard conditions
(49). Cells were cultured at 5 105/ml for 18–24 h at 37°C in 5% CO2 and
washed twice with PBS. Five milliliters of serum-free medium containing
7.5 g/ml DNA (pCI-neo, pCI-neo-chIL-10, or no plasmid), 258 g/ml
chloroquine, and 600 g/ml DEAE-dextran was added to the cells, which
were then incubated for 3 h at 37°C in 5% CO2. The transfection medium
was then removed and cells washed once with PBS. PBS containing 10%
DMSO was added for 2 min, removed, and replaced with 5 ml of growth
medium. After 24-h growth at 37°C in 5% CO2, growth medium was
replaced with serum-free DMEM. The cells were then incubated for 72 h,
after which supernatant was collected and stored at 4°C before use.
IL-10 bioassay
Spleens were removed from 8-wk-old birds postmortem and immediately
placed in DMEM. Using blunt forceps, tissue was then teased apart in 10
ml of DMEM, resulting in a single-cell suspension. Lymphocytes were
isolated over Ficoll-Paque (Amersham Pharmacia Biotech, Arlington
Heights, IL), washed, and resuspended at 5  106 cells/ml in DMEM
containing 2 mg/ml BSA, 1% L-glutamine, 1 U/ml penicillin, and 1 g/ml
streptomycin. This cell suspension was added to round-bottom, 96-well
plates (100 l/well) or 24-well plates (1 ml/well) containing serial 2-fold
dilutions of rchIL-10 (ex-COS), in a final volume of 200 l/well (96-well
plates) or 2 ml/well (24-well plates) in the presence of 1.2 g/ml Con A
(Sigma-Aldrich, St. Louis, MO), 12.5 g/ml PHA (Sigma-Aldrich), or no
mitogen. Negative controls included serial 2-fold dilutions of supernatant
collected from COS-7 cells transfected with pCI-neo alone or medium
alone, with or without mitogen. Assays were conducted in triplicate. Cells
were incubated at 41°C in 5% CO2 for 24 h for RNA analysis (isolated
from 24-well plates) or for 72 h for analysis of IFN- content in the
supernatant.
Supernatants were assayed (in triplicate) for IFN- content using a
quantitative chIFN- capture ELISA (BioSource, Nivelles, Belgium) as
previously described (50) and by bioassay, using the macrophage activa-
tion factor assay, as previously described (51, 52).
Total RNA was isolated from cells in 24-well plates using the RNeasy
mini kit (Qiagen, Valencia, CA) following the manufacturer’s instructions.
Purified RNA was eluted in 50 l of RNase-free water and stored at
70°C. Real-time quantitative RT-PCR was used to determine IFN-
mRNA expression levels in splenocytes treated with rchIL-10 or mock-
transfected COS cell supernatant (at 1/10, 1/100, and 1/1000 dilutions)
with or without mitogenic stimulation (see below).
Experimental design
Three-week-old line 15I and line C.B12 chickens were orally infected with
100 E. maxima sporulated oocysts. Tissue samples were collected from
four birds of each line at 0, 3, 6, and 9 days postinfection (dpi). Small
sections of spleen, cecal tonsil, and small intestine were collected into
RNALater (Qiagen) and stored according to the manufacturer’s instruc-
tions until RNA was purified using the RNeasy mini kit (Qiagen) following
the manufacturer’s instructions. Purified RNA was then eluted in 50 l of
RNase-free water and stored at 70°C.
Quantitative RT-PCR
Cytokine mRNA levels were quantitated using a method based on that
described by Kaiser et al. (51, 53, 54). For both cytokine- and 28S rRNA-
specific amplification, primers and probes were designed using the Primer
Express software program (Applied Biosystems, Foster City, CA). Details
of the probes and primers are given in Table I. All cytokine probes were
designed, from the sequence of the relevant genes, to lie across intron:exon
boundaries. Cytokine and 28S rRNA probes were labeled with the fluo-
rescent reporter dye FAM at the 5 end and with the quencher TAMRA at
the 3 end.
RT-PCR was performed using the Reverse Transcriptase Quantitative
PCR Master Mix kit (Eurogentec, Seraing, Belgium). Amplification and
3 Abbreviations used in this paper: ch, chicken; Ct, threshold cycle; dpi, days postin-
fection; EST, expressed sequence tag; IRE, IFN response element; rch, recombinant
chicken; Sp1, specificity protein 1; BAC, bacterial artificial chromosome.
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detection of specific products were performed using the ABI PRISM 7700
Sequence Detection System (Applied Biosystems) with the following cycle
profile: one cycle of 50°C for 2 min, 96°C for 5 min, 60°C for 30 min, and
95°C for 5 min, and 40 cycles of 94°C for 20 s and 59°C for 1 min.
Quantification was based on the increased fluorescence detected by the
ABI PRISM 7700 Sequence Detection System due to hydrolysis of the
target-specific probes by the 5 nuclease activity of the rTth DNA poly-
merase during PCR amplification. The passive reference dye 6-carboxy-
-rhodamine, which is not involved in amplification, was used to correct
for fluorescent fluctuations, resulting from changes in the reaction condi-
tions, for normalization of the reporter signal. Results are expressed in
terms of the threshold cycle value (Ct), the cycle at which the change in the
reporter dye passes a significance threshold.
Standard curves for the cytokine and 28S rRNA-specific reactions were
generated as previously described (51). Each RT-PCR experiment con-
tained triplicate no-template controls and test samples and a log10 dilution
series of standard RNA. Each experiment was performed in triplicate. Re-
gression analysis of the mean values of five replicate RT-PCRs for the
log10 diluted RNA was used to generate standard curves.
Results
Cloning of the cDNA and gene encoding chIL-10
The chIL-10 cDNA was isolated from an EST library derived from
RNA from a cecal tonsil of a chicken infected with E. tenella. It
encodes a polypeptide of 178 aa (Fig. 1), with a predicted mature
peptide of 162 aa (Fig. 1) and a calculated molecular mass of 20.56
kDa. The 3-untranslated region consists of 1400 nt, with a sin-
gle potential poly(A) signal. It contains 11 copies of the instability
motif AUUUA, commonly found in cytokine and oncogene
mRNAs, which mediates rapid mRNA degradation and is a rec-
ognition site for an RNase E-like activity that cleaves RNA se-
quences in man (55). By contrast, the human and murine IL-10
3-untranslated regions contain seven and six AUUUA motifs,
respectively.
Amino acid sequence comparisons (Fig. 1) show that sequence
identity between chIL-10 and human and murine IL-10 is 45 and
42%, respectively. The mature IL-10 proteins from all species de-
scribed to date, mammals, Fugu, and chicken, all contain four cys-
teine residues. The chIL-10 lacks potential N-linked glycosylation
sites compared with two in murine and one in human IL-10. Native
human IL-10 is unglycosylated, however. Native murine IL-10 is
glycosylated, but this glycosylation is not required for its bioactivity
(1, 56). In common with all other IL-10s described to date, chIL-10
contains the IL-10 family signature motif (G-X-X-K-A-X-X-[DE]-X-
D-[ILV]-[FLY]-[FILMV]-X-X-[ILMV]-[EKQR]), in this case
GIYKAMGEFDIFINYLE.
An unrooted phylogenetic tree was constructed from the amino
acid sequences of chicken, Fugu, and various mammalian IL-10
(Fig. 2). As expected, the analysis clusters chicken and Fugu IL-10
together, apart from the mammalian sequences and separated by a
long branch.
The gene structure of chIL-10 is similar to those of the human,
mouse, and Fugu IL-10 genes, comprising five exons and four
introns (Fig. 3), with similar numbers of amino acids encoded by
the respective exons across species. Overall, the gene is approxi-
mately half the length of the mammalian genes, and 1.5 times
longer than the fish gene.
The chIL-10 promoter
The human IL-10 promoter has been well characterized (57, 58)
(Fig. 4) and can be divided into regions containing elements that
have positive or negative effects on transcription (58). Several
transcriptional regulatory elements were also described in the
Fugu promoter (59) (Fig. 4), and again, these were subdivided into
regions with positive and negative effects. Initial investigation re-
vealed little identity (38% nucleotide identity over 1100 nt) be-
tween the human and chicken promoters. We then predicted tran-
scriptional regulatory elements in the human, Fugu, and chicken
promoters using the AliBaba2 program in the TRANSFAC data-
base. Fig. 4 shows the elements previously identified in the human
promoter and an NF-B site and an IFN response element (IRE)
identified in the current study; elements (NF-B, specificity pro-
tein 1 (Sp1), IRE, PU box, and YY1) were identified in the Fugu
promoter (some previously described), and potential NF-B, IRE,
and Sp1 elements were identified in the chicken promoter. All
three promoters have TATA boxes and at least one each of NF-B
sites, Sp1 sites, and IREs. Other than these features, there is little
similarity between the promoters in terms of numbers or order of
the potential transcription factor binding sites. We have yet to de-
termine whether the chicken promoter can be divided into positive
and negative regulatory regions.
Table I. Real-time quantitative RT-PCR probes and primers
RNA
Target Probe/Primer Sequence
Exon
Boundary Accession No.a
28S Probe 5-(FAM)-AGGACCGCTACGGACCTCCACCA-(TAMRA)-3 X59733
Forward 5-GGCGAAGCCAGAGGAAACT-3
Reverse 5-GACGACCGATTTGCACGTC-3
IFN- Probe 5-(FAM)-TGGCCAAGCTCCCGATGAACGA-(TAMRA)-3 3/4 Y07922
Forward 5-GTGAAGAAGGTGAAAGATATCATGGA-3
Reverse 5-GCTTTGCGCTGGATTCTCA-3
IL-4 Probe 5-(FAM)-AGCAGCACCTCCCTCAAGGCACC-(TAMRA)-3 3/4 AJ621735
Forward 5-AACATGCGTCAGCTCCTGAAT-3
Reverse 5-TCTGCTAGGAACTTCTCCATTGAA-3
TGF-4 Probe 5-(FAM)-ACCCAAAGGTTATATGGCCAACTTCTGCAT-(TAMRA)-3 6/7 M31160
Forward 5-AGGATCTGCAGTGGAGTGGAT-3
Reverse 5-CCCCGGGTTGTGTTGGT-3
IL-10 Probe 5-(FAM)-CGACGATGCGGCGCTGTCA-(TAMRA)-3 3/4 AJ621614
Forward 5-CATGCTGCTGGGCCTGAA-3
Reverse 5-CGTCTCCTTGATCTGCTTGATG-3
a Refers to the genomic DNA sequence.
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FIGURE 1. Alignment of the predicted chIL-10
amino acid sequence with mammalian IL-10, with refer-
ence to secondary structural features and functionally
important residues. Shaded areas represent conservation
of amino acid similarity; the darker the shading, the more
conserved the residue across species. Dashes indicate gaps
in the alignment. The predicted N termini of the mature
proteins are indicated with an arrow. The cysteines con-
served between mammalian and chicken IL-10 are indi-
cated with asterisks. Bases underlined in the chicken
sequence represent the IL-10 family signature residues.
The -helical assignments are based on the structure of
human IL-10 (68). The hydrophobic amino acids at posi-
tions 1 and 4 of the heptad repeats in the amphipathic
helices are indicated with an h. The accession numbers of
the sequences used are as follows: human, M57627; rhe-
sus macaque, L26029; mouse, M37897; rat, L02926;
horse, U38200; llama, AB107649; cow, U00799; sheep,
Z29362; pig, L20001; cat, U39569; dog, U33843; fugu,
AJ539537; and chicken, AJ621254.
FIGURE 2. Unrooted phylogenetic tree of IL-10. For the branch lengths,
the distance given in the scale represents 0.1 amino acid substitution/site. The
accession numbers of the sequences used are given in Fig. 1.
FIGURE 3. Comparison of the gene structures of human, mouse, chicken,
and Fugu IL-10. All four genes are drawn to the same scale. Exons are shown
as boxes; introns are shown as lines joining the boxes. The accession numbers
of the sequences used are: human, U16720; mouse, M84340; chicken,
AJ621614; and Fugu, AJ539537.
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Expression of chIL-10 mRNA in tissues and stimulated lymphoid
cells
Expression of chIL-10 mRNA was assessed by real-time quanti-
tative RT-PCR (Fig. 5) in lymphoid and nonlymphoid tissues from
a line 72 chicken and in stimulated lymphoid cells. The chIL-10
message was constitutively expressed in the thymus, bursa of Fab-
ricius, and cecal tonsil, but not in the spleen or bone marrow. It
was also expressed in mitogen-activated thymocytes, but not in
mitogen-activated splenocytes or bursal cells, and in both primary-
cultured, monocyte-derived macrophages and HD11 cells (a
chicken macrophage cell line (60)) after LPS stimulation. In non-
lymphoid tissues, chIL-10 mRNA expression was detected only in
liver and lung.
Recombinant chIL-10 inhibits IFN- expression from
mitogen-stimulated splenocytes at both mRNA and protein levels
We assessed the ability of rchIL-10 (ex-COS) to inhibit IFN-
expression by splenocytes after mitogen stimulation (Con A and
PHA) at both mRNA (TaqMan, Fig. 6A) and protein (ELISA (Fig.
6B) and bioassay (Fig. 6C)) levels. At the mRNA level (24 h
poststimulation), a 1/10 dilution of rchIL-10 completely inhibited
IFN- expression by splenocytes after stimulation with either Con A
or PHA. At a dilution of 1/100, rchIL-10 completely inhibited IFN-
expression after PHA stimulation of splenocytes, but was only par-
tially effective after Con A stimulation. At a 1/1000 dilution, rchIL-10
FIGURE 4. Comparison of the human, Fugu, and chicken IL-10 pro-
moters. Transcription factor binding sites in the human promoter known to
be involved in control of transcription of human IL-10 (57, 58), or pre-
dicted (IRE) using AliBaba2 (available online at www.gene-regulation-
.com) are shown. For the Fugu promoter, sites shown were previously
described (59) or predicted (Sp1, NF-B, IRE) by AliBaba2. All sites in the
chicken promoter were predicted by AliBaba2. Predicted Sp1 binding sites
are shown as dotted lines. ICS, insulin-like core sequence; GRE, glucocor-
ticoid response element; SRE, serum response element.
FIGURE 5. Expression patterns of chIL-10 in tissues and stimulated
lymphoid cells, as measured by real-time quantitative RT-PCR, with re-
sults expressed as 40  Ct values.
FIGURE 6. Effect of rchIL-10 on the ability of splenocytes to express
IFN- after mitogen stimulation. Splenocytes were unstimulated (no mi-
togen) or were stimulated with Con A or PHA, with different concentra-
tions of rchIL-10 ex-COS, equivalent supernatants from COS cells trans-
fected with the expression vector alone (pCI-neo), or COS cell growth
medium only. A, IFN- mRNA expression at 24 h as measured by real-time
quantitative RT-PCR, expressed as 40  Ct values. a, 1/10 dilution; b,
1/100 dilution; c, 1/1000 dilution. B, IFN- expression (nanograms per
milliliter) at 72 h as measured by capture ELISA. The doubling dilutions
start from a 1/10 dilution. , growth medium only. C, IFN- expression
(OD543) at 72 h as measured by the HD11 bioassay. Dilutions are given in
B. , growth medium only.
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was only partially effective in inhibiting IFN- expression after PHA
stimulation and had no effect on IFN- expression after Con A
stimulation.
At the protein level (72 h poststimulation), rchIL-10 inhibited
the production of IFN-, as measured by ELISA, at high concen-
trations, and this effect titrated out with increasing dilution of
rchIL-10. In general, Con A induced more IFN- than PHA. No
IFN- was detected from unstimulated splenocytes (negative con-
trol; data not shown).
The bioassay measures the ability of IFNs, including IFN-, to
stimulate NO production by a chicken macrophage cell line
(HD11). Recombinant chIL-10 inhibited the production of NO-
inducing agents (probably IFN-) after stimulation of splenocytes
with either mitogen, although much less IFN- was produced after
PHA stimulation of splenocytes. For both mitogens, the inhibition
titrated out with increasing dilution of rchIL-10. Splenocytes stim-
ulated with mitogen were not inhibited by the presence of super-
natant from COS cells transfected with pCI-neo alone (data not
shown).
Levels of expression of IL-10 mRNA correlate with susceptibility
to infection with the intracellular protozoan E. maxima
E. maxima is a chicken-specific intracellular parasite that resides
within enterocytes of the small intestine and induces high levels of
IFN- in the spleen and gut (35, 37). Resistance to primary infec-
tion with Eimeria spp. has been shown to be absolutely dependent
on the ability to express high levels of IFN- (61–64). Bearing in
mind the negative influence of chIL-10 on chIFN- expression
(see above), we chose to assess the expression of IL-10 (and other
cytokines) in resistant (line C.B12) and susceptible (line 15I)
chickens during the course of infection with E. maxima.
The level of resistance/susceptibility of lines C.B12 and 15I to
infection with E. maxima was assessed by the total numbers of
oocysts produced in the feces. The results depicted in Fig. 7A
confirm the relative susceptibility of line 15I compared with line
C.B12 chickens and are consistent with previously published
data (28, 29).
We used real-time quantitative RT-PCR to assess the levels of
mRNA of T1 (IFN-), T2 (IL-4), and regulatory cytokines (TGF-4
and IL-10) expressed in spleen, cecal tonsils, and sections of small
intestine from resistant (line C.B12) and susceptible (line 15I) birds at
3, 6, and 9 dpi with E. maxima. In terms of cytokine mRNA expres-
sion, in the spleen there were no significant differences between con-
trol and infected birds within the same line, between lines, or be-
tween time points for IL-4 and TGF-4 (Fig. 7B). For IFN-, there
was a transient increase in resistant birds at 6 dpi, above levels in
age-matched control birds. The major difference between resistant
and susceptible birds was for IL-10. Constitutive levels of IL-10
mRNA expression in the spleens of resistant birds were 43-fold
lower than in the spleens of susceptible birds. There was also a
transient increase in IL-10 mRNA levels in susceptible birds at 6
dpi, above levels in age-matched controls.
For gut tissues (cecal tonsils and small intestine), levels of
mRNA expression were only measured for IL-10 and IFN-. For
cecal tonsils, there were no significant differences between control
and infected birds within the same line, between lines, or between dpi
(Fig. 7C). In contrast, in the small intestine, IL-10 mRNA expression
was increased significantly above levels in age-matched control birds
after E. maxima infection in susceptible birds, but was not increased
significantly in resistant birds (Fig. 7D). IFN- mRNA levels were
increased significantly in the small intestine of both susceptible and
resistant birds at 6 and 9 dpi (Fig. 7D).
Discussion
We isolated a chIL-10 cDNA from a cecal tonsil cDNA library and
obtained the full gene sequence by direct sequencing of a BAC
positive for chIL-10. Comparisons of the chIL-10 sequence at the
FIGURE 7. Cytokine mRNA expression patterns correlate with suscep-
tibility to infection with E. maxima. A, Total oocyst output in resistant (line
C.B12) and susceptible (line 15I) chickens. Different letters indicate values
that differ significantly at p  0.05. Cytokine mRNA expression was de-
termined in the spleen (B), cecal tonsil (C), and small intestine (D) of
resistant line C.B12 (R) and susceptible line 15I (S) chickens at 3, 6, and
9 dpi with E. maxima. Bars indicate cytokine levels in infected chickens on
each of the days. Lines indicate levels in age-matched uninfected chickens
at 6 dpi. , Values differ significantly at p  0.05.
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amino acid level with its mammalian counterparts show 45 and
42% aa identity with human and mouse IL-10, respectively, some-
what higher than the levels of identity between chickens and mam-
mals for most cytokines cloned to date in the chicken (e.g.,
chIFN- has 32% amino acid identity with human IFN- (65) and
chIL-18 has 30% amino acid identity with human IL-18 (66)), but
similar to the 46% amino acid identity seen between human and
chicken IL-12 (67).
In man, IL-10 has a secondary structure comprising six -heli-
ces (68). The clear heptad repeats with hydrophobic amino acids at
positions 1 and 4 in the assigned amphipathic helices (Fig. 1) sug-
gest that overall the structure of chIL-10 is very much like that in
the human.
We identified the chIL-10 promoter and some of the potential
transcription factor binding sites that lie within it. In general,
chicken cytokine gene promoters share high nucleotide identity
with their mammalian orthologues (43, 67, 69–71). The chIL-10
promoter has little identity with the human IL-10 promoter or with
the Fugu promoter. However, there is a prominent role for Sp1
during control of human IL-10 gene expression (72, 73), and there
are multiple potential Sp1 binding sites in the promoter of the
chIL-10 gene. We have shown that chicken IL-10 is expressed at
the mRNA level, and that rchIL-10 has at least some similar bio-
logical activities to mammalian IL-10. It will be interesting to try
to understand regulation of chIL10 expression because its pro-
moter is very different from those of mammalian IL-10 genes.
RT-PCR analyses of lymphoid tissue samples from a line 72
chicken or activated lymphoid cells showed that chIL-10 was not
expressed constitutively in the spleen or bone marrow, mitogen-
activated splenocytes, or mitogen-activated bursal cells. In non-
lymphoid tissues it was only detected in liver and lung. This pat-
tern of expression mirrors that for IL-10 in human and mouse, but
it is interesting to note that chIL-10 mRNA expression was not
detected in mitogen-activated bursal cells when it was expressed in
the bursa of Fabricius. Either IL-10 is being expressed in the bursa
by non-B cells (e.g., stromal cells), or mitogen stimulation of B
cells switches off IL-10 expression. In mammals, proliferating B
cells and B cell lymphomas constitutively express IL-10 (74, 75).
Recombinant chIL-10, like mammalian IL-10, inhibits the ex-
pression of IFN- by mitogen-activated splenocytes. The results
shown in Fig. 6 are from splenocytes coincubated with IL-10 and
mitogen. Similar results were found when splenocytes were incu-
bated in the presence of IL-10 for 6 h before addition of mitogen
(data not shown).
Our IL-10 cDNA clone was isolated from RNA from a cecal
tonsil of a chicken infected with E. tenella. As such, and consid-
ering the role of IL-10 in controlling the T1-T2 balance and in
resistant/susceptible phenotypes during protozoan infections in
mammals (76, 77), we examined the expression of IL-10 and other
key cytokines (IFN-, IL-4, and TGF-4) during the course of an
Eimeria infection. Tissue samples included spleens, cecal tonsils,
and sections of small intestine from birds sampled at 3, 6, and 9
dpi, from both resistant (line C.B12) and susceptible (line 15I)
lines of chickens. Perhaps not surprisingly, because E. maxima
does not infect the ceca, there were no significant differences in
cytokine expression in the cecal tonsils between control and in-
fected birds within the same line, between lines, or between dpi
(Fig. 7C). For the small intestine, susceptible birds showed signif-
icantly increased expression of IL-10 mRNA after infection,
whereas resistant birds did not. However, both lines of birds
showed similarly increased expression of IFN- mRNA at 6 and 9
dpi (Fig. 7D), which may be considered surprising bearing in mind
the differences in expression levels of IL-10 mRNA. Nonetheless,
in susceptible birds the increased levels of IL-10 may counteract
the protective effect of the IFN-, and this contributes to the in-
ability of these birds to limit the growth of the parasite (Fig. 7A).
For the spleen, resistant birds up-regulated IFN- at 6 dpi com-
pared with those in uninfected birds, whereas the expression of
IL-4 and TGF-4 mRNA was not increased in response to infec-
tion. The most informative result was that IL-10 mRNA levels in
the spleens of uninfected, susceptible birds were 43-fold higher
than those in the spleens of uninfected, resistant birds, suggesting
that levels of constitutive expression of IL-10 mRNA may be de-
pendent on host genetics. Susceptible birds also up-regulated IL-10
mRNA expression at 6 dpi.
Taken together, these data suggest that IL-10 may play a crucial
role in changing the Th bias during infection with E. maxima,
preventing the development of strong, IFN--driven responses,
which have been shown to be crucial for control of Eimeria
infections.
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